Sixiang Shi

4.6k total citations · 2 hit papers
53 papers, 3.8k citations indexed

About

Sixiang Shi is a scholar working on Biomedical Engineering, Biomaterials and Materials Chemistry. According to data from OpenAlex, Sixiang Shi has authored 53 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Biomedical Engineering, 25 papers in Biomaterials and 16 papers in Materials Chemistry. Recurrent topics in Sixiang Shi's work include Nanoparticle-Based Drug Delivery (25 papers), Nanoplatforms for cancer theranostics (25 papers) and Graphene and Nanomaterials Applications (8 papers). Sixiang Shi is often cited by papers focused on Nanoparticle-Based Drug Delivery (25 papers), Nanoplatforms for cancer theranostics (25 papers) and Graphene and Nanomaterials Applications (8 papers). Sixiang Shi collaborates with scholars based in United States, China and Australia. Sixiang Shi's co-authors include Weibo Cai, Todd E. Barnhart, Hao Hong, Shreya Goel, Feng Chen, Charles P. Theuer, Hector F. Valdovinos, Zhuang Liu, Yin Zhang and Liang Cheng and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and ACS Nano.

In The Last Decade

Sixiang Shi

52 papers receiving 3.8k citations

Hit Papers

Iron Oxide Decorated MoS2 Nanosheets with Double PEGylati... 2014 2026 2018 2022 2015 2014 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sixiang Shi United States 31 2.3k 1.4k 1.4k 868 495 53 3.8k
Shreya Goel United States 39 3.1k 1.3× 1.9k 1.4× 1.8k 1.3× 1.2k 1.3× 893 1.8× 74 5.0k
Wenwu Xiao China 32 1.5k 0.6× 1.0k 0.7× 1.6k 1.2× 1.4k 1.7× 297 0.6× 105 4.3k
Ju Hee Ryu South Korea 35 2.5k 1.0× 1.1k 0.8× 1.7k 1.2× 2.3k 2.6× 295 0.6× 72 5.2k
Yu Luo China 36 3.3k 1.4× 1.5k 1.1× 1.9k 1.4× 1.0k 1.2× 193 0.4× 104 4.7k
Chengchao Chu China 37 3.6k 1.5× 2.2k 1.6× 1.3k 0.9× 1.6k 1.8× 241 0.5× 117 5.6k
Haitao Ran China 39 3.9k 1.7× 1.4k 1.0× 1.6k 1.2× 968 1.1× 280 0.6× 109 4.8k
Emily B. Ehlerding United States 33 1.7k 0.7× 1.0k 0.7× 861 0.6× 969 1.1× 895 1.8× 58 3.8k
Preeti Misra India 16 2.2k 0.9× 2.1k 1.5× 1.9k 1.4× 1.5k 1.7× 413 0.8× 44 5.1k
Chunfu Zhang China 34 1.7k 0.7× 765 0.6× 1.2k 0.9× 827 1.0× 230 0.5× 78 2.9k
In‐Cheol Sun South Korea 26 2.4k 1.0× 1.4k 1.0× 1.7k 1.2× 1.2k 1.4× 214 0.4× 41 4.0k

Countries citing papers authored by Sixiang Shi

Since Specialization
Citations

This map shows the geographic impact of Sixiang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sixiang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sixiang Shi more than expected).

Fields of papers citing papers by Sixiang Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sixiang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sixiang Shi. The network helps show where Sixiang Shi may publish in the future.

Co-authorship network of co-authors of Sixiang Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Sixiang Shi. A scholar is included among the top collaborators of Sixiang Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sixiang Shi. Sixiang Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Wenxi, Neetu Singh, David L. Gillespie, et al.. (2025). Image-guided targeting of mitochondrial metabolism sensitizes pediatric malignant rhabdoid tumors to low-dose radiotherapy. Science Advances. 11(21). eadv2930–eadv2930.
2.
Xia, Wenxi, Neetu Singh, Shreya Goel, & Sixiang Shi. (2023). Molecular imaging of innate immunity and immunotherapy. Advanced Drug Delivery Reviews. 198. 114865–114865. 11 indexed citations
3.
Cao, Qizhen, Wanqin Wang, Min Zhou, et al.. (2020). Induction of antitumor immunity in mice by the combination of nanoparticle-based photothermolysis and anti-PD-1 checkpoint inhibition. Nanomedicine Nanotechnology Biology and Medicine. 25. 102169–102169. 30 indexed citations
5.
Shi, Sixiang, Xiaofei Wen, Tingting Li, et al.. (2019). Thermosensitive Biodegradable Copper Sulfide Nanoparticles for Real-Time Multispectral Optoacoustic Tomography. ACS Applied Bio Materials. 2(8). 3203–3211. 14 indexed citations
6.
Shi, Sixiang, Tingting Li, Xiaofei Wen, et al.. (2019). Copper-64 Labeled PEGylated Exosomes for In Vivo Positron Emission Tomography and Enhanced Tumor Retention. Bioconjugate Chemistry. 30(10). 2675–2683. 83 indexed citations
7.
Chen, Feng, Shreya Goel, Sixiang Shi, et al.. (2018). General synthesis of silica-based yolk/shell hybrid nanomaterials and in vivo tumor vasculature targeting. Nano Research. 11(9). 4890–4904. 24 indexed citations
8.
Wang, Dongdong, Ruohong Shi, Jiajia Zhou, et al.. (2018). Photo-Enhanced Singlet Oxygen Generation of Prussian Blue-Based Nanocatalyst for Augmented Photodynamic Therapy. iScience. 9. 14–26. 45 indexed citations
10.
Luo, Haiming, Christopher G. England, Sixiang Shi, et al.. (2016). Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer. Clinical Cancer Research. 22(15). 3821–3830. 30 indexed citations
11.
Xu, Cheng, Sixiang Shi, Liangzhu Feng, et al.. (2016). Long circulating reduced graphene oxide–iron oxide nanoparticles for efficient tumor targeting and multimodality imaging. Nanoscale. 8(25). 12683–12692. 56 indexed citations
12.
Rhode, Peter R., Jack O. Egan, Wenxin Xu, et al.. (2015). Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models. Cancer Immunology Research. 4(1). 49–60. 170 indexed citations
13.
Shi, Sixiang, Hakan Orbay, Yunan Yang, et al.. (2015). PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment. Journal of Nuclear Medicine. 56(6). 927–932. 38 indexed citations
14.
Shi, Sixiang, Zi Gu, Yi‐An Zhu, et al.. (2015). Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging. Scientific Reports. 5(1). 16930–16930. 54 indexed citations
15.
Shi, Sixiang, Hao Hong, Hakan Orbay, et al.. (2015). ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment. European Journal of Nuclear Medicine and Molecular Imaging. 42(8). 1295–1303. 34 indexed citations
16.
Chen, Feng, Hao Hong, Sixiang Shi, et al.. (2014). Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy. Scientific Reports. 4(1). 5080–5080. 199 indexed citations
17.
Shi, Sixiang, Feng Chen, Emily B. Ehlerding, & Weibo Cai. (2014). Surface Engineering of Graphene-Based Nanomaterials for Biomedical Applications. Bioconjugate Chemistry. 25(9). 1609–1619. 101 indexed citations
18.
Chen, Feng, Paul A. Ellison, Christina Lewis, et al.. (2013). Chelator‐Free Synthesis of a Dual‐Modality PET/MRI Agent. Angewandte Chemie International Edition. 52(50). 13319–13323. 106 indexed citations
19.
Guo, Jintang, Hao Hong, Guojun Chen, et al.. (2013). Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles. Biomaterials. 34(33). 8323–8332. 88 indexed citations
20.
Shi, Sixiang, Kai Yang, Hao Hong, et al.. (2013). Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials. 34(12). 3002–3009. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026